Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome

Behavioural Neurology

Volumn 25, Issue 4, 2012, Pages 311-326

  Panou, Theodora ^a   Mastorodemos, Vasileios ^a   Papadaki, Efrosyni ^a   Simos, Panagiotis G ^a   Plaitakis, Andreas ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

executive function; memory; Multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DEMYELINATING DISEASE; EXECUTIVE FUNCTION; FEMALE; HUMAN; LOGICAL MEMORY WMS-III SUBTEST; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MEMORY FOR DIGITS-FORWARD; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RECALL; VERBAL MEMORY;

EID: 84867553378     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.3233/BEN-2012-110201     Document Type: Article

References (67)

1. A. Achiron and Y. Barak, Cognitive impairment in probable multiple sclerosis, Journal of Neurology, Neurosurgery and Psychiatry 74 (2003), 443-446.
2. M.P. Amato, E. Portaccio, M.L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M.L. Bartolozzi, L. Guidi, S. Sorbi, A. Federico and N. De Stefano, Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis, Neurology 71 (2008), 632-638.
3. F. Barkhof, M. Filippi, D.H.Miller et al., Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain 120 (1997), 2059-2069.
4. R.W. Beck, J.D. Trobe, P.S. Moke, R.L. Gal, D. Xing, M.T. Bhatti et al., High and low risk profiles for the development of multiple sclerosis within 10 years after optic neuritis. Experience of the Optic Neuritis treatment trial, Archives of Ophthalmology 121 (2003), 944-949.
5. J.B. Boringa, R.H. Lazeron, I.E. Reuling, H.J. Ader, L. Pfennings, J. Lindeboom et al., The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice, Multiple Sclerosis 7 (2001), 263-267.
6. P.A. Brex, O. Ciccarelli, J.I. O'Riordan, M. Sailer, A.J. Thompson and D.H. Miller, A longitudinal study of abnormalities on MRI and disability from multiple sclerosis, New England Journal of Medicine 246 (2002), 158-164.
7. S. Cader, A. Cifelli, Y. Abu-Omar, J. Palace and P.M. Matthews, Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis, Brain 129 (2006), 527-537.
8. M.M. Callanan, S.G. Logsdail, M.A. Ron et al., Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis, Brain 112 (1989), 361-374.
9. G. Comi, M. Rovaris, L. Leocani, V. Martinelli and M. Filippi, Clinical and MRI assessment of brain damage in MS, Neurological Science 22 (2001), 123-127.
10. C. Confavreux, S. Vukusic and P. Adeleine, Early clinical predictors and progression of irreversible disability inmultiple sclerosis: an amnesic process, Brain 126 (2003), 770-782.
11. C.M. Dalton, P.A. Brex, K.A. Miszkiel, S.J. Hickman, D.G. MacManus, G.T. Plant et al., Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis, Annals of Neurology 52 (2002), 47-53.
12. C.M. Dalton, D.T. Chard, G.R. Davies, K.A. Miszkiel, D.R. Altmann, K. Fernando, G.T. Plant, A.J. Thompson and D.H. Miller, Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes, Brain 127 (2004), 1101-1107.
13. L.M.J. De Sonneville, J.B. Boringa, I.E.W. Reuling, R.H.C. Lazeron, H.J. Ad̀er and C.H. Polman, Information processing characteristics in subtypes of multiple sclerosis, Neuropsychologia 40 (2002), 1751-1765.
14. S.D. Legge,M.C. Piattella, C. Pozzilli, P. Pantano, F. Caramia, I.F. Pestalozza, A. Paolillo and G.L. Lenzi, Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis, Multiple Sclerosis 9 (2003), 302-306.
15. M. Eriksson, O. Andersen and B. Runmarker, Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis, Multiple Sclerosis 9 (2003), 260-274.
16. A. Feinstein, L.D. Kartsounis, D.H. Miller, B.D. Youl and M.A. Ron, Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive psychiatric and MRI follow up study, Journal of Neurology, Neurosurgery and Psychiatry 55 (1992), 869-876.
17. A. Feinstein, B.D. Youl and M. Ron, Acute optic neuritis. A cognitive and magnetic resonance imaging study, Brain 115 (1992), 1403-1415.
18. L. Feuillet, F. Reuter, B. Audoin, I. Mallikova, K. Barrau, A.A. Cherif and J. Pelletier, Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis, Multiple Sclerosis 13 (2007), 124-127.
19. L.K. Fisniku, D.T. Chard, J.S. Jackson, V.M. Anderson, D.R. Altmann, K.R. Miszkiel, A.J. Thompson and D.H. Miller, Gray matter atrophy is related to long-term disability in multiple sclerosis, Annals of Neurology 64 (2008), 247-254.
20. P. Flachenecker, T. Kumpfel, B. Kallmann, M. Gottschalk, O. Grauer, P. Rieckmann, C. Trenkwalder and K.V. Toyka, Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters, Multiple Sclerosis 8 (2002), 523-526.
21. J. Foong, L. Rozewicz, G. Quaghebeur, C.A. Davie, L.D. Kartsounis, A.J. Thompson, D.H. Miller and M.A. Ron, Executive function in multiple sclerosis. The role of frontal lobe pathology, Brain 120 (1997), 15-26.
22. K. Fountoulakis, A. Iacovides, S. Kleanthous, S. Samolis, S.G. Kaprinis, K. Sitzoglou, G. Kaprinis and P. Bech, Reliability, Validity and Psychometric Properties of the Greek Translation of the Center for Epidemiological Studies-Depression (CESD) Scale, BMC Psychiatry 1 (2001).
23. K.N. Fountoulakis, M. Papadopoulou, S. Kleanthous, A. Papadopoulou, V. Bizeli, I. Nimatoudis, A. Iacovides and G. Kaprinis, Reliability and psychometric properties of the Greek translation of the State-Trait Anxiety Inventory, Annals of General Psychiatry 5 (2006), 2.
24. B.I. Glanz, C.M. Holland, S.A. Gauthier, E.L. Amunwa, Z. Liptak, M.K. Houtchens, R.A. Sperling, S.J. Khoury, C.R.G. Guttmann and H.L.Weiner, Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis, Multiple Sclerosis 13 (2007), 1004-1010.
25. O. Godefroy, Frontal syndrome and disorders of executive functions, Journal of Neurology 250 (2003), 1-6.
26. I. Grant, W.I. McDonald, M.R. Trimble et al., Deficient learning and memory in early and middle phases of multiple sclerosis, Journal of Neurology, Neurosurgery and Psychiatry 47 (1984), 250-255.
27. A.M. Hubley and D. Tremblay, Comparability of total score performance on the Rey-Osterrieth Complex Figure and a modified Taylor Complex Figure, Journal of Clinical and Experimental Neuropsychology 24 (2002), 370-382.
28. L. Jacobs, R. Rudick and J. Simon, Extended observations on MS patients treated with IM interferon-beta1a (Avonex): implications for modern MS trials and therapeutics, Journal of Neuroimmunology 107 (2000), 167-173.
29. L. Kappos, C.H. Polman, M.S. Freedman, G. Edan, H.P. Hartung, D.H. Miller, X. Montalban, F. Barkhof, L. Bauer, P. Jakobs, C. Pohl and R. Sandbrink, Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes, Neurology 67 (2006), 1242-1249.
30. L. Kappos, A. Traboulsee, C. Constantinescu, J.P. Er̈alinna, F. Forrestal, P. Jongen, J. Pollard, M. Sandberg-Wollheim, C. Sindic, B. Stubinski, B. Uitdehaag and D. Li, Longterm subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS, Neurology 67 (2006), 944-953.
31. M. Khalil, C. Enzinger, C. Langkammer, K. Petrovic, M. Loitfelder, M. Tscherner, M. Jehna, G. Bachmaier, M. Wallner-Blazek, S. Ropele, R. Schmidt, S. Fuchs and F. Fazekas, Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome, Multiple Sclerosis 17(2) (2011), 173-180.
32. L.B. Krupp, N.G. LaRocca, J. Muir-Nash and A.D. Steinberg, The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus, Archives of Neurology 46 (1989), 1121-1123.
33. J.F. Kurtzke, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology 33 (1983), 1444-1452.
34. N.I. Landrø, E.G. Celius and H. Sletvold, Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis (MS), Journal of Neurological Sciences 217 (2004), 211-216.
35. N. Le Carret, S. Auriacombe, L. Letenneur, V. Bergua, J.F. Dartigues and C. Fabrigoule, Influence of education on the pattern of cognitive deterioration in AD patients: the cognitive reserve hypothesis, Brain and Cognition 57 (2005), 120-126.
36. S.J. Logsdail, M.M. Callanan and M.A. Ron, Psychiatric morbidity in patients with clinically isolated lesions of the type seen in multiple sclerosis: a clinical and MRI study, Psychological Medicine 18 (1988), 355-364.
37. O. Lyon-Caen, R. Jouvent, S. Hauser,M.P. Chaunu, N. Benoit, D. Widlocher et al., Cognitive function in recent-onset demyelinating diseases, Archives of Neurology 43 (1986), 1138-1141.
38. V. Mastorodemos, H. Nikolakaki, M. Tzagournissakis, D. Kotzamani, T. Panou, C. Spanaki, G. Klados, T.Maris, E.Kontolaimaki, K. Psaroudaki, G. Chlouverakis, G. Georgakakis and A. Plaitakis, Benign Multiple Sclerosis in Crete, Multiple Sclerosis 16 (2010), 701-706.
39. F. Mattioli, C. Stampatori and R. Capra, The effect of natalizumab on cognitive function in patients with relapsingremitting multiple sclerosis: preliminary results of a 1-year follow-up study, Neurological Science 32 (2011), 83-88.
40. L. Messinis, E. Lyros, V. Georgiou and P. Papathanasopoulos, Benton visual retention test performance in normal adults and acute stroke patients: Demographic considerations, discriminant validity, and test-retest reliability, Clinical Neuropsychologist 23(6) (2009), 962-977.
41. W.I. McDonald, A. Compston, G. Edan,D.Goodkin, H.P. Hartung, F.D. Lublin, H.F. McFarland, D.W. Paty, C.H. Polman, S.C. Reingold, M. Sandberg-Wollheim, W. Sibley, A. Thompson, S. van den Noort, B.Y. Weinshenker and J.S. Wolinsky, Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis, Annals of Neurology 50 (2001), 121-127.
42. D.H.Miller, B.G.Weinshenker, M. Filippi, B.L. Banwell, J.A. Cohen, M.S. Freedman, S.L. Galetta, M. Hutchinson, R.T. Johnson, L. Kappos, J. Kira, F.D. Lublin, H.F. McFarland, X. Montalban, H. Panitch, J.R. Richert, S.C. Reingold and C.H. Polman, Differential diagnosis of suspected multiple sclerosis: a consensus approach, Multiple Sclerosis 14 (2008), 1157-1174.
43. A. Minneboo, F. Barkhof, C.H. Polman, B.M. Uitdehaag, D.L. Knol and J.A. Castelijns, Infratentorial lesions predict longterm disability in patients with initial findings suggestive of multiple sclerosis, Archives of Neurology 61 (2004), 217-221.
44. S.P. Morrisey, D.H. Miler, B.E. Kendall et al., The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis, Brain 116 (1993), 135-146.
45. P. O' Connor, A.S. Detsky, C. Tansey and W. Kucharczik, Effect of diagnostic testing for multiple sclerosis on patient health perceptions, Archives of Neurology 29 (1994), 3-5.
46. J.I. O'Riordan, A.J. Thompson, D.P. Kingsley et al., The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up, Brain 121 (1998), 495-503.
47. T. Panou, P.G. Simos, V. Mastorodemos and A. Plaitakis, Verbal episodic memory for passages in relapsing remitting MS: Proactive interference or serial position effects? (unpublished data).
48. T. Panou, P.G. Simos, V. Mastorodemos, C. Fassaraki and A. Plaitakis, Variables affecting memory deficits in relapsingremitting MS, The Internet Journal of Neurology 11 (2009), 1.
49. F. Patti, M.P. Amato, S. Bastianello, L. Caniatti, E. Di Monte, P. Ferrazza, B. Goretti, P. Gallo, V. Brescia Morra, S. Lo, Fermo, O. Picconi, M.R. Tola, M. Trojano and COGIMUS Study Group, Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline inmildly disabled patients with relapsing-remitting multiple sclerosis, Multiple Sclerosis 16 (2010), 68.
50. L. Pelosi, J.M. Geesken, M. Holly et al., Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patientswith clinically isolated myelopathy, Brain 120 (1997), 2039-2058.
51. C.H. Polman, S.C. Reingold, G. Edan, M. Filippi, H.P. Hartung, L. Kappos, F.D. Lublin, L.M. Metz, H.F. McFarland, P.W. O'Connor,M. Sandberg-Wollheim, A.J. Thompson, B.G. Weinshenker and J.S. Wolinsky, Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria", Annals of Neurology 58 (2005), 840-846.
52. E. Portaccio, B. Goretti, V. Zipoli, G. Siracusa, S. Sorbi and M.P. Amato, A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis, Clinical Neuropsychology 23 (2009), 268-275.
53. C. Potagas, C. Mitsonis, L. Watier, G. Dellatolas, A. Retziou, P.A. Mitropoulos, C. Sfagos and D. Vassilopoulos, Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: A prospective study, Multiple Sclerosis 14(9) (2008), 1262-1268.
54. C.M. Poser, D.W. Paty, L. Scheinberg, W.I. McDonald, F.A. Davis, G.C. Ebers et al., New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Annals of Neurology 13 (1983), 227-231.
55. P. Preziosa, M.A. Rocca, S. Mesaros, E. Pagani, T. Stosic-Opincal, K. Kacar, M. Absinta, D. Caputo, J. Drulovic, G. Comi and M. Filippi, Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study, Radiology 260 (2011), 541-550.
56. L.S. Radloff, The CES-D Scale: A self-report depression scale for research in the general population, Applied Psychological Measurement 1 (1977), 385-401.
57. S.M. Rao, G.J. Leo, L. Bernardin and F. Unverzagt, Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction, Neurology 41 (1991), 685-691.
58. P.G. Simos, D. Kasselimis, A. Mouzaki, Age, gender, and education effects on vocabulary measures in Greek, Aphasiology 25 (2011), 475-491.
59. P.G. Simos, D. Kasselimis, E. Papastefanakis and D. Panou, Episodic verbal memory tests: Normative data for Greek adults. Applied Psychology Laboratory, University of Crete, Greece, 2009.
60. C.D. Spielberger, State-Trait Anxiety Inventory for Adults, Redwood City California: Mind Garden, 2005.
61. M. Tintoŕe, A. Rovira, J. Rio et al., Baseline MRI predicts future attacks and disability in clinically isolated syndromes, Neurology 67 (2006), 968-972.
62. G. Vallar and C. Papagno, Neuropsychological Impairments of Verbal Short-term Memory, in: The Handbook of Memory Disorders (2nd Edition), A.D. Baddeley, M.D. Kopelman and B.A.Wilson, eds, Chichester, UK: JohnWiley, 2002, pp. 249-270.
63. D. Wechsler, Wechsler Memory Scale-III (WMS-III), San Antonio, TX: The Psychological Corporation. Reproduced by permission, 1997.
64. D. Wechsler, Wechsler Abbreviated Scale of Intelligence (WASI), San Antonio, TX: NCS Pearson Inc. Reproduced by permission, 1999.
65. W.B. Whitten, Output interference and long-term serial position effects, Journal of Experimental Psychology: Human Learning and Memory 4 (1978), 685-692.
66. J. Wuerfel, J. Bellmann-Strobl, P. Brunecker, O. Aktas, H. McFarland, A. Villringer and F. Zipp, Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study, Brain 127 (2004), 111-119.
67. V. Zipoli, B. Goretti, B. Hakiki, G. Siracusa, S. Sorbi, E. Portaccio and M.P. Amato, Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes, Multiple Sclerosis 16 (2010), 62-67.